Clinical trial
Understanding the Role of Monoaminergic Neurotransmitters in Cognitive Functions Using Fast-cyclic Voltammetry in Patients With Neurological and Psychiatric Diseases Eligible for Neurosurgical Treatment (COGAMINE)
NCT06853977 is registered in ClinicalTrials.gov with Centre Hospitalier St Anne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Understanding the Role of Monoaminergic Neurotransmitters in Cognitive Functions Using Fast-cyclic Voltammetry in Patients With Neurological and Psychiatric Diseases Eligible for Neurosurgical Treatment (COGAMINE)
- Lead sponsor
- Centre Hospitalier St Anne
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 20, 2025
- Completion date
- June 30, 2035
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
candidates for awake surgery, candidates for deep brain stimulation, candidates for invasive s-eeg, neurological diseases or conditions, psychiatric diseases